EPIDERMOLYSIS BULLOSA (EB)
Clinical trials for EPIDERMOLYSIS BULLOSA (EB) explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA (EB) trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA (EB), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Oxygen chamber trial tests hope for dozens of Tough-to-Treat illnesses
Disease control Not yet recruitingThis study is gathering information to see how well hyperbaric oxygen therapy (HBOT) works for over 40 different health conditions. It will enroll about 100 people who have been referred for HBOT for conditions like Long COVID, Crohn's disease, and various ulcers. The main goal i…
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE4 • Sponsor: Jay C. Buckey Jr. • Aim: Disease control
Last updated Mar 23, 2026 15:14 UTC
-
Year-Long skin cream safety test for fragile skin condition
Symptom relief Not yet recruitingThis study follows up on previous research to check the long-term safety of SD-101 cream when applied daily to the entire body for up to one year. It includes 80 people with different types of epidermolysis bullosa (EB), a condition that causes fragile, blistering skin. The main …
Matched conditions: EPIDERMOLYSIS BULLOSA (EB)
Phase: PHASE3 • Sponsor: Paradigm Therapeutics • Aim: Symptom relief
Last updated Apr 01, 2026 14:40 UTC